Amoxi-TAB Tablet
Amoxi-TAB is an FDA-approved preparation containing Amoxi-TAB, for veterinary use. Available by prescription.
Veterinarians most commonly consider Amoxi-TAB® for the management of infections where an oral tablet format is preferred for consistent dosing and ease of administration. It is frequently a point of discussion for periodontal infections, respiratory tract challenges and uncomplicated systemic infections involving susceptible Gram-positive and Gram-negative organisms. By interfering with the structural integrity of the bacterial organism, your veterinarian can manage the physiological progression of the infection.
At a pharmacological level, the active ingredient in Amoxi-TAB® acts as a bactericidal agent by inhibiting the synthesis of the bacterial cell wall. It binds to specific penicillin-binding proteins (PBPs) located inside the bacterial cell wall, which may help address the final stage of peptidoglycan synthesis. This interference leads to the weakening of the cell wall and eventual lysis (bursting) of the bacteria. While this formulation is commonly considered against many common pathogens, it is susceptible to degradation by beta-lactamase enzymes produced by certain resistant bacteria. Your veterinarian will determine whether Amoxi-TAB® is appropriate based on your pet’s clinical signs and any diagnostic testing results.
The actions described here reflect the product's FDA-approved labeling; your veterinarian determines the appropriate use for your animal.
Prescription only. Use only under the direction of a licensed veterinarian. This information is not a substitute for veterinary diagnosis, prescribing or monitoring.
Commonly observed effects of Amoxi-TAB® include gastrointestinal changes such as vomiting, loose stools or a decrease in appetite. These shifts are often managed by administering the medication with a small meal, as directed by your veterinarian. Allergic reactions, though less frequent, can occur and may manifest as skin rashes, hives or respiratory changes. Owners should watch for these signs and contact their veterinarian promptly if any unexpected behavioral or physical changes occur after administration.
This medication is typically used with extra caution or avoided in patients with a known hypersensitivity to penicillins or cephalosporins. It is strictly contraindicated for use in certain small mammals—such as rabbits, guinea pigs and hamsters—as it can cause life-threatening shifts in their delicate digestive microflora. Before starting a protocol, ensure your veterinarian has a complete history of all other prescriptions and supplements your pet is receiving. Your veterinarian is the right person to provide guidance on the necessary duration of use and the most commonly considered monitoring schedule to ensure the management approach remains suitable for your pet's individual health status.
Yes. Amoxi-TAB® is a prescription antibiotic and can only be dispensed by a licensed pharmacy upon receipt of a valid authorization from a licensed veterinarian. Mixlab verifies all authorizations before any medication is prepared or shipped to your home.
Yes. While Amoxi-TAB® is a specific commercial tablet, Mixlab can compound the active ingredient, amoxicillin, into specialized strengths or alternative flavored dosage forms—such as flavored oral liquids or chewable may be considered in cases of—if your veterinarian determines a customized preparation better suits your pet's needs. The decision between a commercial and compounded product rests with the prescribing veterinarian.
Veterinarians often suggest administering Amoxi-TAB® with a small amount of food to help manage the potential for stomach upset or nausea. Providing a meal at the time of administration can support better tolerance of the medication while your pet is undergoing the protocol.
Amoxi-TAB® is a specific brand of amoxicillin manufactured as a tablet for veterinary use. While the active ingredient remains the same across different brands, your veterinarian may select Amoxi-TAB® for its specific tablet sizes and established history of use in feline and canine patients.
